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Introduction {#phy214275-sec-0001}
============

Optimal exercise performance requires an integrated organ system response. The entire cardiovascular system, pulmonary, systemic circulations enable increased gas exchange and oxygen availability to exercising muscles. The cardiovascular adaptations to maximal exercise include an increase in cardiac output resulting from an increased heart rate and to a lesser degree stroke volume, as well as a widening of the arteriovenous oxygen difference (Weiner, [1983](#phy214275-bib-0026){ref-type="ref"}). The rate of skeletal muscle blood flow degree and degree of oxygen consumption are increased (Weiner, [1983](#phy214275-bib-0026){ref-type="ref"}). The net effect of acute systemic hypoxia in quiescent skeletal muscle is vasodilation that occurs despite significant reflex increases in muscle sympathetic nerve activity. This vasodilation increases tissue perfusion and oxygen delivery to maintain tissue oxygen consumption (Dinenno, [2016](#phy214275-bib-0003){ref-type="ref"}). Although several mechanisms may be involved, there is evidence for local vasodilatory control mechanisms involving nitric oxide (NO) and prostaglandins (PGs) (Dinenno, [2016](#phy214275-bib-0003){ref-type="ref"}). When the stimulus is exacerbated *via* combined (sub)maximal exercise and systemic hypoxia to cause further red blood cell (RBC) deoxygenation, local vasodilation augments skeletal muscle blood flow. ATP release and nitrite reduction to NO have been shown to be involved in regulating this response (Dinenno, [2016](#phy214275-bib-0003){ref-type="ref"}; Zhang et al., [2018](#phy214275-bib-0029){ref-type="ref"}; Pernow et al., [2019](#phy214275-bib-0019){ref-type="ref"}).

PGs and other eicosanoids, such thromboxanes (TXs), leukotrienes (LTs), epoxides, and hydro(peroxy) fatty acids (or oxylipins) are lipid peroxidation products of 20‐carbon (eicosa‐) polyunsaturated fatty acids (PUFA). These products are generated by three separate enzyme families, namely cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) expoygenases. These pathways catalyse lipid peroxidation in a highly regulated manner generating stereo and regio‐specific products (Fig. [1](#phy214275-fig-0001){ref-type="fig"}). Their expression is highly tissue‐localized and varies with inflammatory activation state. Primary products of COX, LOX, and CYP are metabolized, depending on cell type, into secondary eicosanoids and their metabolites, some of which are also potently bioactive (Fig. [1](#phy214275-fig-0001){ref-type="fig"}). The major metabolic pathways of PUFA epoxides are incorporation into phospholipids and hydrolysis to the corresponding PUFA diols by soluble epoxide hydrolase (sEH) (Spector and Kim, [2015](#phy214275-bib-0022){ref-type="ref"}). In a number of vascular beds, CYP‐derived epoxyeicosatrienoic acids (EETs) and other epoxides, such as 17,18‐epoxyeicosatetraenoic acid (17,18‐EEQ), can function as endothelium‐derived hyperpolarizing factors (EDHF) that contribute to vasodilation (Hu and Kim, [1993](#phy214275-bib-0011){ref-type="ref"}; Campbell et al., [1996](#phy214275-bib-0002){ref-type="ref"}; Hercule et al., [2007](#phy214275-bib-0009){ref-type="ref"}).

![Short‐term maximal exercise associated with increased vasopressor and shear stress, red blood cell (RBC)‐endothelial interactions and tissue hypoxia affecting the content of epoxy‐metabolites in RBCs. The proposal illustrates cytochrome P450 epoxygenase (CYP) and 12‐ and 15‐lipoxygenase (LOX)/ CYP omega‐hydroxylase pathways. Linoleic (LA), arachidonic (AA), eicosapentaenoic (EPA), and docosahexaenoic acids (DHA) are converted to epoxyoctadecenoic acids (EpOMEs, e.g., 9,10‐EpOME), epoxyeicosatrienoic acid (EETs, e.g., 5,6‐EET, 11,12‐EET), epoxyeicosatetraenoic acids (EEQs) and epoxydocosapentaenoic acids (EDPs, e.g., 19,20‐EDP) by CYP, respectively. EpOMEs, EETs, EEQs and EDPs are metabolized to dihydroxyctadecenoic acids (DiHOMEs, e.g., 9,10‐DiHOME), dihydroxyeicosatrienoic acids (DHETs, e.g., 5,6‐DHET), dihydroxyeicosatetraenoic acids (DiHETEs) and dihydroxydocosapentaenoic acids (DiHDPAs, e.g., 19,20‐DiHDPA), respectively, by the soluble epoxide hydrolase (sEH) enzyme. LA, AA, EPA, and DHA are converted to hydroperoxylinoleic acids (HpODEs), hydroxyoctadecadienoic acids (HODEs), hydroxydocosahexaenoic acids (HDHAs), hydroperoxyeicosatetraenoic acids (HPETEs) and hydroxyeicosatetraenoic acids (HETEs) by LOX, CYP omega/(omega‐1)‐hydroxylase and peroxidase pathways. The metabolites measured within these pathways track the changes observed in LA, AA, EPA, and DHA, respectively. Arrows demarcate metabolic pathways evaluated.](PHY2-7-e14275-g001){#phy214275-fig-0001}

Recently, RBCs (\~3 kg in human body) have been implicated to serve as a reservoir for epoxide fatty acids, in particular CYP‐derived EETs, which on release may act in a vasoregulatory capacity (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). Furthermore, sEH in the RBC and the increase in EETs resulting from its pharmacological inhibition presumably contributes to a greater degree on regional blood flows than sEH inhibition localized in the arterial wall (Yu et al., [2004](#phy214275-bib-0028){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). Both *cis*‐ and *trans*‐EETs are stored in phospholipids and in RBCs. The greater vasodilator potency of *trans*‐ vs. *cis*‐EETs may contribute to the antihypertensive effects of sEH inhibitors in rats (Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). However, it is unknown whether physical exercise affects the RBC epoxy fatty acid status. We tested the hypothesis that acute, maximal physical exercise might affect RBC epoxy fatty acids. Maximal treadmill Bruce test was used to ensure sufficient and robust metabolic and hemodynamic response in healthy individuals. RBC lipidomics was performed using liquid chromatography‐mass spectrometry in tandem (LC--MS/MS).

Methods {#phy214275-sec-0002}
=======

Prior to participation in the study, six healthy volunteers (5 male and 1 female; age 38 ± 15 years; body mass index 27.9 ± 6.6 kg/m^2^) signed informed consent forms which outlined the procedures to be taken and the possible risks involved. The study was approved by the Charité University Medicine institutional review board on the use of humans in research. All subjects were non‐trained and not taking medications. Recruitment was primarily *via* person‐to‐person interview. Following a routine physical examination at baseline levels each subject underwent a maximal treadmill Bruce test, which is recommended by guidelines for ergometry of the German Society of Cardiology (Bruce et al., [1973](#phy214275-bib-0001){ref-type="ref"}; Trappe and Lollgen, [2000](#phy214275-bib-0025){ref-type="ref"}). The test was preceded by 2 x 3 min warm up periods (stages 1 and 2 of the Bruce protocol) during which treadmill speed was maintained at a constant speed of 2.7 km/h and at zero or 5 per cent grade (Table [1](#phy214275-tbl-0001){ref-type="table"}) (Gollasch et al., [2019](#phy214275-bib-0007){ref-type="ref"}). Treadmill speed and grade were then increased at three min intervals. The test was terminated when the subjects informed the investigator that they could no longer proceed. Workload was assessed in metabolic equivalents (METs) (Table [1](#phy214275-tbl-0001){ref-type="table"}).

###### 

Bruce protocol and estimated metabolic equivalents of task (METs).

  Stages   Duration (in min)   Grade (in %)   Speed (in km/h)   Speed (in MPH)   METs
  -------- ------------------- -------------- ----------------- ---------------- ---------
  1        3                   0              2.7               1.7              Warm up
  2        3                   5              2.7               1.7              Warm up
  3        3                   10             2.7               1.7              5
  4        3                   12             4.0               2.5              7
  5        3                   14             5.4               3.4              10
  6        3                   16             6.7               4.2              13
  7        3                   18             8.0               5.0              15
  8        3                   20             8.8               5.5              18
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Heart rates were monitored continuously by heart‐rate monitor worn around the subject's torso (Polar T31, Polar Electro, Kempele, Finland). Arterial pressure was measured *via* a sphygmomanometer (Critikon, Inc., Johnson & Johnson, New Jersey, USA), which comprised an inflatable (Riva‐Rocci) cuff placed around the upper arm. Venous blood was collected from a catheter placed in a contralateral forearm vein (i.e., the antecubital vein) of each subject in the sitting position prior to the exercise test (−10 mins, *P1*), after termination of the test (exhaustion, *P3*), and 10 min after the end of the running test (recovery period, *P4*) (Fig. [2](#phy214275-fig-0002){ref-type="fig"}). An additional blood sample was collected in each subject during running when the heart rate reached 150 beats per minute (*P2*). All samples were analyzed for total and free RBC epoxide lipid mediator status. RBCs were separated from EDTA blood by centrifugation and metabolites were determined by liquid chromatography tandem mass (LC--MS/MS) spectrometry as described in Fischer et al., ([2014](#phy214275-bib-0005){ref-type="ref"}). Serum lactate was determined in blood samples obtained from ear lobe at rest and at maximal workload (Fig. [2](#phy214275-fig-0002){ref-type="fig"}).

![Following abbreviations are: HF, heart rate; BP, blood pressure; RBC, red blood cell; epoxy, epoxide fatty acids; METs, metabolic equivalents of task.](PHY2-7-e14275-g002){#phy214275-fig-0002}

Descriptive statistics were calculated and variables were examined for meeting assumptions of normal distribution without skewness and kurtosis. In order to determine statistical significance between the trials at the various time intervals, one‐way repeated measures analysis of variance (ANOVA) was conducted and the 0.05 level of significance (*P*) was chosen. The analysis included Mauchly\'s test of sphericity followed by applying the test of within‐subjects' effects with Greenhouse--Geisser correction, which is used for repeated‐measures ANOVA when the assumption of sphericity is violated. When significant differences were found, Tukey's honestly significant difference post hoc test was used for pairwise comparisons. The nonparametric test (distribution‐free) Friedman's test was used when the normal distribution was violated. Planned hypotheses (one‐tailed or two‐tailed paired *t*‐tests as appropriate) were tested to follow up the initial ANOVA findings. All data are presented as mean ± SD. All statistical analyses were performed using SPSS Statistics software (IBM Corporation, Armonk, NY, USA) or All‐Therapy statistics beta (AICBT Ltd, Vancouver, Canada).

Results {#phy214275-sec-0003}
=======

Hemodynamic and metabolic response {#phy214275-sec-0004}
----------------------------------

Exercise significantly increased heart rate, systolic, and diastolic blood pressure (Table [2](#phy214275-tbl-0002){ref-type="table"}). Data prior to the exercise test (−10 mins, *P1*), after termination of the test (exhaustion, *P3*), and 10 min after the end of the running test (recovery period, *P4*) are shown in Figure [2](#phy214275-fig-0002){ref-type="fig"}. An additional blood sample (*P2*) was obtained throughout exercise when the heart rate reached 150 beats per minute. After exercise, heart rate and systolic blood pressure returned to resting levels (*P1)* in the recovery period (*P4*) (Table [2](#phy214275-tbl-0002){ref-type="table"} **,** *P *\> 0.05, Tukey's post hoc test) (Gollasch et al., [2019](#phy214275-bib-0007){ref-type="ref"}). All participants terminated exercise at a maximal workload of 13.50 ± 1.97 METs (Bruce stage, 6.33 ± 0.82). Exercise increased lactate concentrations from 1.3 + 0.3 (*P1*) to 9.5 ± 2.1 mmol/L (*P3*) (*P* \< 0.0001, *t*‐test).

###### 

Effects of exercise on hemodynamics (means ± SD, *n* = 6).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameter                                  Time point 1, *P1* (rest)   Time point 2, *P2* (HF 150)   Time point 3, *P3* (exhaustion)   Time point 4,\    Greenhouse--Geisser,\
                                                                                                                                         *P4* (recovery)   *P* value
  ------------------------------------------ --------------------------- ----------------------------- --------------------------------- ----------------- -----------------------
  Heart rate (beats per min)                 71 ± 10                     150                           185 ± 6                           94 ± 11           \<0.001

  Systolic arterial blood pressure (mm Hg)   135.3 ± 9.1                 n.d.                          190.3 ± 16.6                      127.5 ± 13.1      \<0.001

  Diastolic arterial blood pressure          81.2 ± 14.4                 n.d.                          90.7 ± 16.4                       76.3 ± 10.2       0.097
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

n.d., not determined
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Fatty acid‐derived *cis*‐mediators {#phy214275-sec-0005}
----------------------------------

Since the impact of acute exercise on individual RBC epoxide fatty acid status is unknown, we initially used an explorative statistical approach and measured the total *cis‐*metabolites in RBCs at: baseline (rest, *P1*), the time when heart rate reached 150 beats per min (*P2*), exhaustion (*P3*), and recovery (*P4*) (Table [3](#phy214275-tbl-0003){ref-type="table"}). Our ANOVA analysis indicated differences in the total levels of epoxyoctadecenoic acids (9,10‐EpOME, 12,13‐EpOME), epoxyeicosatrienoic acids (5,6‐EET, 11,12‐EET, 14,15‐EET), and epoxydocosapentaenoic acids (16,17‐EDP, 19,20‐EDP) (Table [3](#phy214275-tbl-0003){ref-type="table"}). However, we did not observe differences in the total levels of epoxyeicosatetraenoic acids (5,6‐EEQ, 8,9‐EEQ, 11,12‐EEQ, 14,15‐EEQ), 8,9‐EET, 10,11‐EDP, 13,14‐EDP, hydroxyeicosapentaenoic acids (5‐HEPE, 8‐HEPE, 9‐HEPE, 12‐HEPE, 15‐HEPE, 18‐HEPE) and hydroxyeicosatetraenoic acids (5‐HETE, 8‐HETE, 9‐HETE, 11‐HETE, 12‐HETE, 15‐HETE). We identified no differences in hydroxydocosahexaenoic acids (4‐HDHA, 7‐HDHA, 8‐HDHA, 10‐HDHA, 11‐HDHA, 13‐HDHA, 14‐HDHA, 16‐HDHA, 17‐HDHA, 20‐HDHA) and 13‐HODE levels. Of note, RBCs did not contain relevant levels of 19‐HEPE, 20‐HEPE, 19‐HETE, and 20‐HETE (detection threshold, \<0.05 ng/g) (Table [3](#phy214275-tbl-0003){ref-type="table"}). The data demonstrate an accumulation of total 5,6‐EET, 11,12‐EET, 14,15‐EET, 16,17‐EDP, 19,20‐EDP 9,10‐EpOME, and 12,13‐EpOME concentrations in RBCs at exhaustion (for all *P* \< 0.05, *t*‐tests), which are potent vasodilators (Siegfried et al., [1990](#phy214275-bib-0021){ref-type="ref"}; Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}; Morin et al., [2011](#phy214275-bib-0018){ref-type="ref"}). Accumulation of total 5,6‐EET, 11,12‐EET, 14,15‐EET, 16,17‐EDP, 19,20‐EDP, 9,10‐EpOME and 12,13‐EpOME levels in RBCs persisted in the recovery period (10 min) (*P* \< 0.05, *t*‐tests). The data suggest that exercise leads to an accumulation of various CYP (i.e. *cis*) epoxy‐metabolites into membrane‐bound compartments of RBCs under exhaustive exercise or in ischemia in healthy individuals, which on release may act in a vasoregulatory capacity.

###### 

Total *cis*‐metabolites in erythrocytes in response to exhaustive exercise (*n* = 6).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolite (ng/g)   Time point 1 (rest), *P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  ------------------- --------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  13‐HODE             1258.0 ± 382.54             1124.22 ± 214.01             1296.36 ± 330.21                 1329.40 ± 329.97               0.550

  9,10‐EpOME          101.62 ± 11.50              122.80 ± 13.14               125.09 ± 16.78                   128.38 ± 17.81                 Friedman\
                                                                                                                                               *P* = 0.002

  12,13‐EpOME         99.25 ± 12.74               119.61 ± 15.71               125.09 ± 18.65                   129.29 ± 22.75                 0.001

  9,10‐DiHOME         3.34 ± 1.50                 6.30 ± 5.59                  3.48 ± 1.00                      4.68 ± 2.99                    Friedman\
                                                                                                                                               *P* = 0.108

  12,13‐DiHOME        7.10 ± 2.80                 11.06 ± 7.50                 7.68 ± 2.06                      9.97 ± 5.00                    Friedman\
                                                                                                                                               *P* = 0.056

  5,6‐EET             54.75 ± 6.93                64.05 ± 5.61                 61.67 ± 9.06                     63.80 ± 8.11                   0.021

  8,9‐EET             70.70 ± 11.08               77.28 ± 7.25                 75.20 ± 12.31                    79.33 ± 11.92                  0.247

  11,12‐EET           71.69 ± 9.72                83.11 ± 9.75                 80.74 ± 13.51                    85.32 ± 12.54                  0.039

  14,15‐EET           79.97 + 13.23               93.61 ± 12.03                89.06 ± 14.96                    94.77 ± 14.49                  0.038

  5,6‐DHET            4.67 ± 0.46                 5.19 ± 0.51                  4.77 ± 0.15                      5.14 ± 0.63                    0.191

  8,9‐DHET            3.29 ± 0.44                 3.74 ± 0.37                  3.57 ± 0.46                      3.74 ± 0.51                    0.202

  11,12‐DHET          1.97 ± 0.36                 2.28 ± 0.25                  2.11 ± 0.21                      2.18 ± 0.30                    0.279

  14,15‐DHET          1.68 ± 0.32                 1.75 ± 0.15                  1.71 ± 0.13                      1.79 ± 0.24                    0.790

  5,6‐EEQ             1.14 ± 0.63                 1.23 ± 0.58                  1.09 ± 0.46                      1.17 ± 0.60                    0.10

  8,9‐EEQ             3.00 ± 1.15                 3.03 ± 0.75                  3.26 ± 0.93                      3.22 ± 1.11                    0.673

  11,12‐EEQ           2.38 ± 0.78                 2.48 ± 0.65                  2.24 ± 0.59                      2.57 ± 0.82                    0.433

  14,15‐EEQ           2.67 ± 0.86                 2.75 ± 0.62                  2.87 ± 0.66                      2.91 ± 0.80                    0.583

  17,18‐EEQ           3.62 ± 0.94                 3.69 ± 0.98                  3.62 ± 0.78                      3.64 ± 1.02                    0.988

  5,6‐DiHETE          0.78 ± 0.44                 0.45 ± 0.40                  0.72 ± 0.61                      0.16 ± 0.38                    0.090

  8,9‐DiHETE          0                           0                            0                                0                              n/a

  11,12‐DiHETE        0                           0                            0                                0                              n/a

  14,15‐DiHETE        0                           0                            0                                0                              n/a

  17,18‐DiHETE        3.49 ± 1.33                 3.95 ± 0.99                  4.50 ± 0.83                      3.82 ± 0.64                    0.153

  7,8‐EDP             29.72 ± 5.06                33.36 ± 6.52                 31.70 ± 7.26                     33.30 ± 7.33                   0.175

  10,11‐EDP           42.64 ± 7.31                48.27 ± 10.14                45.13 ± 9.83                     48.17 ± 11.21                  0.122

  13,14‐EDP           21.34 ± 4.31                25.22 ± 6.70                 23.56 ± 5.30                     25.42 ± 6.01                   0.096

  16,17‐EDP           27.04 ± 3.95                32.08 ± 6.97                 30.73 ± 6.33                     32.70 ± 7.22                   0.021

  19,20‐EDP           26.50 ± 4.83                30.84 ± 7.20                 29.00 ± 6.00                     31.32 ± 6.45                   0.015

  7,8‐DiHDPA          0.79 ± 0.31                 0.78 ± 0.27                  0.83 ± 0.19                      0.98 ± 0.19                    0.157

  10,11‐DiHDPA        0.17 ± 0.10                 0.18 ± 0.10                  0.19 ± 0.11                      0.18 ± 0.09                    0.671

  13,14‐DiHDPA        0.23 ± 0.18                 0.24 ± 0.19                  0.22 ± 0.17                      0.23 ± 0.18                    Friedman\
                                                                                                                                               *P* = 0.800

  16,17‐DiHDPA        0.25 ± 0.30                 0.27 ± 0.31                  0.38 ± 0.31                      0.34 ± 0.29                    0.501

  19,20‐DiHDPA        0.05 ± 0.13                 0.07 ± 0.16                  0.07 ± 0.16                      0.00 ± 0.00                    Friedman\
                                                                                                                                               *P* = 1.000

  5‐HETE              214.23 ± 135.63             143.99 ± 39.23               189.26 ± 66.21                   190.40 ± 44.62                 0.382

  8‐HETE              96.31 ± 52.88               72.09 ± 17.92                88.21 ± 24.46                    89.10 ± 18.74                  0.428

  9‐HETE              116.82 ± 54.61              91.29 ± 21.93                106.86 ± 30.34                   113.23 ± 22.46                 0.430

  11‐HETE             249.20 ± 130.33             181.35 ± 40.77               225.53 ± 59.37                   248.41 ± 56.47                 0.353

  12‐HETE             118.25 ± 54.03              90.30 ± 20.67                114.03 ± 37.09                   112.58 ± 22.98                 0.384

  15‐HETE             114.64 ± 70.53              81.36 ± 22.06                106.69 ± 34.94                   105.07 ± 28.06                 0.426

  19‐HETE             0                           0                            0                                0                              n/a

  20‐HETE             0                           0                            0                                0                              n/a

  5‐HEPE              8.61 ± 5.43                 5.92 ± 1.53                  7.59 ± 2.24                      8.09 ± 2.18                    0.364

  8‐HEPE              3.25 ± 1.95                 2.18 ± 0.33                  2.98 ± 0.98                      2.86 ± 0.98                    0.365

  9‐HEPE              4.70 ± 2.52                 3.81 ± 1.29                  4.54 ± 1.27                      4.53 ± 1.53                    0.449

  12‐HEPE             5.09 ± 2.33                 4.17 ± 1.29                  4.75 ± 1.70                      5.14 ± 1.92                    0.508

  15‐HEPE             4.93 ± 2.27                 4.14 ± 0.66                  4.29 ± 1.02                      4.48 ± 0.88                    Friedman\
                                                                                                                                               *P* = 0.772

  18‐HEPE             15.62 ± 8.93                12.08 ± 4.44                 13.69 ± 3.72                     14.21 ± 3.70                   0.496

  19‐HEPE             0                           0                            0                                0                              n/a

  20‐HEPE             0                           0                            0                                0                              n/a

  10,17‐DiHDHA        0                           0                            0                                0                              n/a

  4‐HDHA              116.85 ± 52.93              81.07 ± 11.71                111.98 ± 31.57                   111.76 ± 27.96                 0.343

  7‐HDHA              28.35 ± 8.70                23.03 ± 3.32                 27.20 ± 5.92                     29.38 ± 6.92                   0.358

  8‐HDHA              48.33 ± 12.77               36.50 ± 5.34                 47.08 ± 12.37                    49.39 ± 12.78                  0.249

  10‐HDHA             34.29 ± 12.83               25.41 ± 3.45                 32.34 ± 8.87                     34.11 ± 9.39                   0.358

  11‐HDHA             29.71 ± 10.19               23.66 ± 4.09                 30.18 ± 9.39                     30.88 ± 8.57                   0.448

  13‐HDHA             48.34 ± 12.09               39.15 ± 5.08                 48.70 ± 13.74                    49.00 ± 11.68                  0.350

  14‐HDHA             60.42 ± 14.68               49.70 ± 7.96                 61.95 ± 18.41                    62.66 ± 17.61                  0.404

  16‐HDHA             44.51 ± 11.95               35.68 ± 4.31                 43.14 ± 11.49                    44.97 ± 11.68                  0.382

  17‐HDHA             75.87 ± 22.48               58.99 ± 6.36                 79.46 ± 17.22                    76.49 ± 21.83                  0.283

  20‐HDHA             65.09 ± 21.77               47.56 ± 6.85                 63.43 ± 16.05                    16.05 ± 17.91                  0.285

  21‐HDHA             0                           0                            0                                0                              n/a

  22‐HDHA             0                           0                            0                                0                              n/a
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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To provide possible insights into the nature of this accumulation, we measured free epoxy and hydroxy metabolites in RBCs. We detected significant levels of free 13‐HODE, 9,10‐EpOME, 12,13‐EpOME, 9,10‐DiHOME, 12,13‐DiHOME, 14,15‐DHET, 12‐HETE, 12‐HEPE, 4‐HDHA, 14‐HDHA, and 16‐HDHA in RBCs (i.e., above the detection level, cf. methods), although no changes occurred in response to exercise (Table [4](#phy214275-tbl-0004){ref-type="table"}). Exercise did not induce significant levels of the majority of free fatty acid metabolites and PGs, including 5,6‐EET, 8,9‐EET, 11,12‐EET, 14,15‐EET, 5,6‐DHET, 8,9‐DHET, 5,6‐EEQ, 8,9‐EEQ, 11,12‐EEQ, 14,15‐EEQ, 17,18‐EEQ, 8,9‐DiHETE, 11,12‐DiHETE, 14,15‐DiHETE, 17,18‐DiHETE, 7,8‐EDP, 10,11‐EDP, 13,14‐EDP, 16,17‐EDP, 19,20‐EDP, 7,8‐DiHDPA, 10,11‐DiHDPA, 13,14‐DiHDPA, 16,17‐DiHDPA, 19,20‐DiHDPA, LTB4, LXA4, 5‐HETE, 8‐HETE, 9‐HETE, 11‐HETE, 15‐HETE, 19‐HETE, 20‐HETE, 5‐HEPE, 8‐HEPE, 15‐HEPE, 18‐HEPE, 19‐HEPE, 20‐HEPE, 10,17‐DiHDHA, 7‐HDHA, 8‐HDHA, 10‐HDHA, 11‐HDHA, 13‐HDHA, 17‐HDHA, 20‐HDHA, 21‐HDHA, 22‐HDHA, PGH2, PGE2, 15‐keto‐PGE2, 13,14‐dihydro‐15‐keto‐PGE2, Bicyclo PGE2 (a), Bicyclo PGE2 (b), PGD2, PGI2, 15‐deoxy‐delta 12,14‐PGI2, PGF2a, TXB2, 11‐dehydro TXB2, 6‐keto‐PGF1a, PGE3, TXB3, 11‐dehydro TXB3, d17‐6‐keto‐PGF1a (Table [4](#phy214275-tbl-0004){ref-type="table"}; detection level of 0.05 ng/g, each). The data suggest that maximal exercise does not result in accumulation of free epoxy‐metabolites and other fatty acid metabolites in RBCs for their uptake into membrane‐bound compartments.

###### 

Free *cis‐*metabolites in red blood cells (RBCs) in response to exhaustive exercise (*n* = 6).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolite (ng/g)            Time point 1 (rest),*P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  ---------------------------- -------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  13‐HODE                      63.81 ± 27.94              58.56 ± 3.82                 53.29 ± 5.15                     53.36 ± 8.77                   0.474

  9,10‐EpOME                   9.05 ± 1.17                1.17 ± 1.23                  8.31 ± 0.82                      8.34 ± 1.17                    0.377

  12,13‐EpOME                  9.17 ± 1.39                9.70 ± 0.95                  8.97 ± 0.92                      9.06 ± 0.93                    0.612

  9,10‐DiHOME                  1.87 ± 0.17                2.12 ± 0.43                  1.90 ± 0.23                      1.85 ± 0.22                    Friedman\
                                                                                                                                                       *P* = 0.512

  12,13‐DiHOME                 4.18 ± 0.43                4.63 ± 0.51                  4.09 ± 0.44                      4.46 ± 0.18                    0.076

  5,6‐EET                      0                          0                            0                                0                              n/a

  8,9‐EET                      0                          0                            0                                0                              n/a

  11,12‐EET                    0                          0                            0                                0                              n/a

  14,15‐EET                    0                          0                            0                                0                              n/a

  5,6‐DHET                     0                          0                            0                                0                              n/a

  8,9‐DHET                     0                          0                            0                                0                              n/a

  14,15‐DHET                   0.81 ± 0.40                0.85 ± 0.43                  1.04 ± 0.05                      0.84 ± 0.41                    Friedman\
                                                                                                                                                       *P* = 0.398

  5,6‐EEQ                      0                          0                            0                                0                              n/a

  8,9‐EEQ                      0                          0                            0                                0                              n/a

  11,12‐EEQ                    0                          0                            0                                0                              n/a

  14,15‐EEQ                    0                          0                            0                                0                              n/a

  17,18‐EEQ                    0                          0                            0                                0                              n/a

  8,9‐DiHETE                   0                          0                            0                                0                              n/a

  11,12‐DiHETE                 0                          0                            0                                0                              n/a

  14,15‐DiHETE                 0                          0                            0                                0                              n/a

  17,18‐DiHETE                 0                          0                            0                                0                              n/a

  7,8‐EDP                      0.05 ± 0.14                0                            0                                0                              n/a

  10,11‐EDP                    0                          0                            0                                0                              n/a

  13,14‐EDP                    0                          0                            0                                0                              n/a

  16,17‐EDP                    0                          0                            0                                0                              n/a

  19,20‐EDP                    0                          0                            0                                0                              n/a

  7,8‐DiHDPA                   0                          0                            0                                0                              n/a

  10,11‐DiHDPA                 0                          0                            0                                0                              n/a

  13,14‐DiHDPA                 0                          0                            0                                0                              n/a

  16,17‐DiHDPA                 0                          0                            0                                0                              n/a

  19,20‐DiHDPA                 0                          0                            0                                0                              n/a

  LTB4                         0                          0                            0                                0                              n/a

  LXA4                         0                          0                            0                                0                              n/a

  5‐HETE                       0                          0                            0                                0                              n/a

  8‐HETE                       0                          0                            0                                0                              n/a

  9‐HETE                       0                          0                            0                                0                              n/a

  11‐HETE                      0                          0                            0                                0                              n/a

  12‐HETE                      10.25 ± 2.84               12.26 ± 4.22                 14.83 ± 7.32                     13.77 ± 6.74                   0.278

  15‐HETE                      0                          0                            0                                0                              n/a

  19‐HETE                      0                          0                            0                                0                              n/a

  20‐HETE                      0                          0                            0                                0                              n/a

  5‐HEPE                       0                          0                            0                                0                              n/a

  8‐HEPE                       0                          0                            0                                0                              n/a

  12‐HEPE                      1.34 ± 0.58                1.74 ± 0.78                  1.88 ± 1.20                      1.91 ± 1.02                    Friedman\
                                                                                                                                                       *P* = 0.073

  15‐HEPE                      0                          0                            0                                0                              n/a

  18‐HEPE                      0                          0                            0                                0                              n/a

  19‐HEPE                      0                          0                            0                                0                              n/a

  20‐HEPE                      0                          0                            0                                0                              n/a

  10,17‐DiHDHA                 0                          0                            0                                0                              n/a

  4‐HDHA                       2.82 ± 1.04                3.12 ± 1.03                  2.83 ± 0.75                      2.87 ± 0.67                    0.488

  7‐HDHA                       0                          0                            0                                0                              n/a

  8‐HDHA                       0                          0                            0                                0                              n/a

  10‐HDHA                      0                          0                            0                                0                              n/a

  11‐HDHA                      0                          0                            0                                0                              n/a

  13‐HDHA                      0                          0                            0                                0                              n/a

  14‐HDHA                      2.35 ± 1.44                2.16 ± 1.19                  2.16 ± 0.97                      2.77 ± 1.48                    0.341

  16‐HDHA                      0.13 ± 0.21                0.29 ± 0.37                  0.24 ± 0.26                      0.18 ± 0.21                    Friedman\
                                                                                                                                                       *P* = 0.446

  17‐HDHA                      0                          0                            0                                0                              n/a

  20‐HDHA                      0                          0                            0                                0                              n/a

  21‐HDHA                      0                          0                            0                                0                              n/a

  22‐HDHA                      0                          0                            0                                0                              n/a

  PGH2                         0                          0                            0                                0                              n/a

  PGE2                         0                          0                            0                                0                              n/a

  15‐keto‐PGE2                 0                          0                            0                                0                              n/a

  13,14‐dihydro‐15‐keto‐PGE2   0                          0                            0                                0                              n/a

  Bicyclo PGE2 (a)             0                          0                            0                                0                              n/a

  Bicyclo PGE2 (b)             0                          0                            0                                0                              n/a

  PGD2                         0                          0                            0                                0                              n/a

  PGI2                         0                          0                            0                                0                              n/a

  15‐deoxy‐delta 12,14‐PGI2    0                          0                            0                                0                              n/a

  PGF2a                        0                          0                            0                                0                              n/a

  TXB2                         0                          0                            0                                0                              n/a

  11‐dehydro TXB2              0                          0                            0                                0                              n/a

  6‐keto‐PGF1a                 0                          0                            0                                0                              n/a

  PGE3                         0                          0                            0                                0                              n/a

  TXB3                         0                          0                            0                                0                              n/a

  11‐dehydro TXB3              0                          0                            0                                0                              n/a

  d17‐6‐keto‐PGF1a             0                          0                            0                                0                              n/a
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Diols {#phy214275-sec-0006}
-----

The main pathway of EET, EpOME, EEQ, and EDP metabolism is conversion to DHETs, DiHOMEs, dihydroxyeicosatetraenoic acids (DiHETEs), and dihydroxydocosapentaenoic acids (DiHDPAs) by the sEH, respectively (Fig. [1](#phy214275-fig-0001){ref-type="fig"}) (Spector et al., [2004](#phy214275-bib-0023){ref-type="ref"}). Since acute exercise might have caused EET, EpOME, EEQ, and EDP accumulation rapidly degraded to their diols, we analyzed their individual levels (Table [3](#phy214275-tbl-0003){ref-type="table"}) and the sums of the individual break‐down products and their respective diols (Table [5](#phy214275-tbl-0005){ref-type="table"}). Exercise did not change the levels of 9,10‐DiHOME, 12,13‐DiHOME, 5,6‐DHET, 8,9‐DHET, 11,12‐DHET, 14,15‐DHET, 5,6‐DiHETE, 17,18‐DiHETE, 7,8‐DiHDPA, 10,11‐ DiHDPA, 13,14‐DiHDPA, 16,17‐DiHDPA, 19,20‐DiHDPA (Table [3](#phy214275-tbl-0003){ref-type="table"}), but increased the levels 9,10‐EpOME, 12,13‐EpOME, 5,6‐EET, 11,12‐EET, 14,15‐EET, 16,17‐EDP, and 19,20‐EDP plus their respective diols (Table [5](#phy214275-tbl-0005){ref-type="table"}).

###### 

Concentrations of individual total *cis‐*epoxides plus their respective diols in erythrocytes in response to exhaustive exercise (*n* = 6).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Epoxides or Diols (ng/g)   Time point 1 (rest), *P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  -------------------------- --------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  9,10‐\                     104.97 ± 12.95              129.09 + 15.44               128.57 ± 17.62                   133.06 ± 18.67                 \<0.001
  EpOME\                                                                                                                                              
  +\                                                                                                                                                  
  9,10‐DiHOME                                                                                                                                         

  12,13‐EpOME+12,13‐DiHOME   106.35 ± 15.49              130.68 ± 19.66               132.77 ± 20.26                   139.26 ± 26.13                 \<0.001

  5,6‐EET+5,6‐DHET           59.42 ± 6.92                69.24 ± 5.40                 66.45 ± 9.00                     68.94 ± 8.52                   0.012

  8,9‐EET+8,9‐DHET           73.99 ± 11.02               81.03 ± 7.10                 78.78 ± 12.05                    83.07 ± 11.91                  0.217

  11,12 EET+11,12‐DHET       73.68 ± 9.71                85.39 ± 9.65                 82.85 ± 13.42                    87.50 ± 12.57                  0.035

  14,15‐EET+14,15‐DHET       81.65 ± 13.31               95.37 ± 12.07                90.76 ± 14.88                    96.56 ± 14.54                  0.036

  5,6‐EEQ+5,6‐DiHETE         1.92 ± 0.84                 1.69 ± 0.71                  1.82 ± 0.91                      1.33 ± 0.56                    0.376

  8,9‐EEQ+8,9‐DiHETE         3.00 ± 1.15                 3.04 ± 0.75                  3.26 ± 0.94                      3.22 ± 1.11                    0.673

  11,12‐EEQ+11,12‐DiHETE     2.39 ± 0.78                 2.49 ± 0.64                  2.24 ± 0.59                      2.57 ± 0.83                    0.435

  14,15‐EEQ+14,15‐DiHETE     2.67 ± 0.86                 2.75 ± 0.62                  2.87 ± 0.66                      2.91 ± 0.80                    0.589

  17,18‐EEQ+17,18‐DiHETE     7.11 ± 1.80                 7.64 ± 0.88                  8.13 ± 1.18                      7.46 ± 1.54                    0.174

  7,8‐EDP+7,8‐DiHDPA         30.52 ± 5.35                34.15 ± 6.69                 32.53 ± 7.36                     34.28 ± 7.36                   0.170

  10,11‐EDP+10,11‐DiHDPA     42.81 ± 7.39                48.46 ± 10.19                45.32 ± 9.89                     48.35 ± 11.27                  0.120

  13,14‐EDP+13,14‐DiHDPA     21.57 ± 4.44                25.46 ± 6.85                 23.78 ± 5.47                     25.65 ± 6.19                   0.096

  16,17‐EDP+16,17‐DiHDPA     27.29 ± 4.07                32.36 ± 7.06                 31.12 ± 6.61                     33.05 ± 7.51                   0.020

  19,20‐EDP+19,20‐DiHDPA     26.55 ± 4.84                30.90 ± 7.20                 29.07 ± 6.10                     31.32 ± 6.45                   0.016
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Diol/epoxide ratios {#phy214275-sec-0007}
-------------------

We next calculated diol/epoxide ratios in RBCs and analyzed their changes in response to exhaustive exercise and post exercise (Table [6](#phy214275-tbl-0006){ref-type="table"}). Our ANOVA analysis revealed no alterations in ratios for each substrate class in RBCs *in vivo* during and post exercise. Similar results were found for the individual metabolites (Table [7](#phy214275-tbl-0007){ref-type="table"}). Furthermore, we detected that the four classes of epoxy‐metabolites are unequally hydrolyzed to appear in the RBCs (Greenhouse‐Geisser, *P1*, *P* = 0.001). Notably, we found that EEQs are preferentially metabolized into their diols (ratio DiHETE/EEQs at *P1*, 0.356 ± 0.100) compared to EpOMEs, EETs and EDPs (ratios diols/epoxy‐metabolites at *P1*, 0.051 ± 0.013, 0.043 ± 0.007, 0.009 ± 0.004, respectively) (Table [6](#phy214275-tbl-0006){ref-type="table"}). The following order of ratios was identified: DiHETEs/EEQs\> DHETs/EETs = DiHOMEs/EpOMEs\> DiHDPA/EDPs in RBCs (paired *t*‐tests, one‐tailed, Bonferroni correction). In our earlier studies, we observed similar results for plasma diols/epoxides in plasma (Gollasch et al., [2019](#phy214275-bib-0007){ref-type="ref"}). The ratios did not change in response to exercise (Table [6](#phy214275-tbl-0006){ref-type="table"}). This state‐of‐affairs was also the case for to the individual diol/epoxide metabolites in RBCs (Table [7](#phy214275-tbl-0007){ref-type="table"}). In our previous studies, we obtained similar results for plasma diols/epoxides in plasma (Gollasch et al., [2019](#phy214275-bib-0007){ref-type="ref"}). The observed findings are unlikely to result from changes in the levels of arachidonic, linoleic acid, docosahexanoic, or eicosapentaenoic acid (Fig. [1](#phy214275-fig-0001){ref-type="fig"}) as we previously found that acute, maximal exercise is insufficient to change their levels (Gollasch et al., [2019](#phy214275-bib-0007){ref-type="ref"}).

###### 

Ratios estimated using total concentrations of *cis‐*epoxides and diols in erythrocytes in response to exhaustive exercise (*n* = 6).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Epoxides or Diols (ng/g) or Ratios   Time point 1 (rest),*P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  ------------------------------------ -------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  9,10‐EpOME+12,13‐EpOME               200.87 ± 24.05             242.41 ± 28.57               250.19 ± 35.01                   257.68 ± 40.38                 0.001

  9,10‐DiHOME\                         10.44 ± 4.29               17.36 ± 13.09                11.15 ± 3.02                     14.65 ± 7.90                   0.255
  +\                                                                                                                                                           
  12,13‐DiHOME                                                                                                                                                 

  Ratio (9,10‐DiHOME\                  0.0507 ± 0.0133            0.0707 ± 0.0534              0.0443 ± 0.0085                  0.0561 ± 0.0283                0.335
  +\                                                                                                                                                           
  12,13‐DiHOME)\                                                                                                                                               
  /\                                                                                                                                                           
  (9,10‐EpOME\                                                                                                                                                 
  +\                                                                                                                                                           
  12,13‐EpOME)                                                                                                                                                 

  5,6‐EET\                             277.11 ± 40.02             318.06 ± 33.40               306.68 ± 49.10                   323.22 ± 46.52                 0.058
  +\                                                                                                                                                           
  8,9‐EET\                                                                                                                                                     
  +\                                                                                                                                                           
  11,12 EET\                                                                                                                                                   
  +\                                                                                                                                                           
  14,15‐EET                                                                                                                                                    

  5,6‐DHET\                            11.63 ± 1.39               12.97 ± 1.07                 12.16 ± 0.76                     12.85 ± 1.47                   0.248
  +\                                                                                                                                                           
  8,9‐DHET\                                                                                                                                                    
  +\                                                                                                                                                           
  11,12‐DHET\                                                                                                                                                  
  +\                                                                                                                                                           
  14,15‐DHET                                                                                                                                                   

  Ratio\                               0.0427 ± 0.0076            0.0413 ± 0.0062              0.0409 ± 0.0094                  0.0404 ± 0.0064                0.763
  (5,6‐DHET\                                                                                                                                                   
  +\                                                                                                                                                           
  8,9‐DHET\                                                                                                                                                    
  +\                                                                                                                                                           
  11,12‐DHET\                                                                                                                                                  
  +\                                                                                                                                                           
  14,15‐DHET)\                                                                                                                                                 
  /\                                                                                                                                                           
  (5,6‐EET\                                                                                                                                                    
  +\                                                                                                                                                           
  8,9‐EET\                                                                                                                                                     
  +\                                                                                                                                                           
  11,12 EET\                                                                                                                                                   
  +\                                                                                                                                                           
  14,15‐EET)                                                                                                                                                   

  5,6‐EEQ\                             12.81 ± 4.28               13.19 ± 3.43                 13.09 ± 3.18                     13.51 ± 4.22                   0.814
  +\                                                                                                                                                           
  8,9‐EEQ\                                                                                                                                                     
  +\                                                                                                                                                           
  11,12‐EEQ\                                                                                                                                                   
  +\                                                                                                                                                           
  14,15‐EEQ\                                                                                                                                                   
  +\                                                                                                                                                           
  17,18‐EEQ                                                                                                                                                    

  5,6‐DiHETE\                          4.28 ± 1.15                4.41 ± 0.76                  5.22 ± 0.63                      3.98 ± 0.48                    0.091
  +\                                                                                                                                                           
  8,9‐DiHETE\                                                                                                                                                  
  +\                                                                                                                                                           
  11,12‐DiHETE\                                                                                                                                                
  +\                                                                                                                                                           
  14,15‐DiHETE\                                                                                                                                                
  +\                                                                                                                                                           
  17,18‐DiHETE                                                                                                                                                 

  Ratio\                               0.3566 ± 0.1004            0.3622 ± 0.1344              0.4199 ± 0.1104                  0.3165 ± 0.1001                0.071
  (5,6‐DiHETE\                                                                                                                                                 
  +\                                                                                                                                                           
  8,9‐DiHETE\                                                                                                                                                  
  +\                                                                                                                                                           
  14,15‐DiHETE\                                                                                                                                                
  +\                                                                                                                                                           
  17,18‐DiHETE)\                                                                                                                                               
  /\                                                                                                                                                           
  (5,6‐EEQ\                                                                                                                                                    
  +\                                                                                                                                                           
  8,9‐EEQ\                                                                                                                                                     
  +\                                                                                                                                                           
  11,12‐EEQ\                                                                                                                                                   
  +\                                                                                                                                                           
  14,15‐EEQ\                                                                                                                                                   
  +\                                                                                                                                                           
  17,18‐EEQ)                                                                                                                                                   

  7,8‐EDP\                             147.24 ± 24.88             169.77 ± 36.84               160.14 ± 34.18                   170.91 ± 37.80                 0.057
  +\                                                                                                                                                           
  10,11‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  13,14‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  16,17‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  19,20‐EDP                                                                                                                                                    

  7,8‐DiHDPA\                          1.50 ± 0.77                1.55 ± 0.63                  1.68 ± 0.78                      1.75 ± 0.62                    0.331
  +\                                                                                                                                                           
  10,11‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  13,14‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  16,17‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  19,20‐DiHDPA                                                                                                                                                 

  Ratio\                               0.0098 ± 0.0042            0.0090 ± 0.0029              0.0101 ± 0.0032                  0.0101 ± 0.0024                0.686
  (7,8‐DiHDPA\                                                                                                                                                 
  +\                                                                                                                                                           
  10,11‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  13,14‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  16,17‐DiHDPA\                                                                                                                                                
  +\                                                                                                                                                           
  19,20‐DiHDPA)\                                                                                                                                               
  /\                                                                                                                                                           
  (7,8‐EDP\                                                                                                                                                    
  +\                                                                                                                                                           
  10,11‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  13,14‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  16,17‐EDP\                                                                                                                                                   
  +\                                                                                                                                                           
  19,20‐EDP)                                                                                                                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Ratios estimated using individual concentrations of total *cis‐*epoxides and their diols in erythrocytes in response to exhaustive exercise (*n* = 6).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ratios          Time point 1 (rest),*P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  --------------- -------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  9,10‐DiHOME\    0.0320 ± 0.0097            0.0508 ± 0.0460              0.0275 ± 0.0052                  0.0364 ± 0.0238                0.319
  /\                                                                                                                                      
  9,10‐EpOME                                                                                                                              

  12,13‐DiHOME\   0.0698 ± 0.0169            0.0912 ± 0.0606              0.0610 ± 0.0117                  0.0755 ± 0.0322                0.345
  /\                                                                                                                                      
  12,13‐EpOME                                                                                                                             

  5,6‐DHET\       0.0865 ± 0.0130            0.0818 ± 0.0123              0.0791 ± 0.0146                  0.0810 ± 0.0088                0.592
  /\                                                                                                                                      
  5,6‐EET                                                                                                                                 

  8,9‐DHET\       0.0476 ± 0.0098            0.0490 ± 0.0075              0.0491 ± 0.0129                  0.0482 ± 0.0101                0.911
  /\                                                                                                                                      
  8,9‐EET                                                                                                                                 

  11,12‐DHET\     0.0282 ± 0.0065            0.0279 ± 0.0052              0.0270 ± 0.0071                  0.0261 ± 0.0050                0.618
  /\                                                                                                                                      
  11,12‐EET                                                                                                                               

  14,15‐DHET\     0.0215 ± 0.0045            0.0190 ± 0.0027              0.0199 ± 0.0053                  0.0192 ± 0.0035                0.503
  /\                                                                                                                                      
  14,15‐EET                                                                                                                               

  5,6‐DiHETE\     0.8995 ± 0.6214            0.4716 ± 0.5161              0.6989 ± 0.6652                  0.2429 ± 0.5950                0.088
  /\                                                                                                                                      
  5,6‐EEQ                                                                                                                                 

  8,9‐DiHETE\     0                          0                            0                                0                              n/a
  /\                                                                                                                                      
  8,9‐EEQ                                                                                                                                 

  11,12‐DiHETE\   0                          0                            0                                0                              n/a
  /\                                                                                                                                      
  11,12‐ EEQ                                                                                                                              

  14,15‐DiHETE\   0                          0                            0                                0                              n/a
  /\                                                                                                                                      
  14,15‐EEQ                                                                                                                               

  17,18‐DiHETE\   0.9919 ± 0.3072            1.1739 ± 0.4890              1.2901 ± 0.3398                  1.100 ± 0.2536                 0.286
  /\                                                                                                                                      
  17,18‐EEQ                                                                                                                               

  7,8‐DiHDPA\     0.0261 ± 0.0067            0.0235 ± 0.0063              0.0267 ± 0.0058                  0.0309 ± 0.0105                0.270
  /\                                                                                                                                      
  7,8‐EDP                                                                                                                                 

  10,11‐DiHDPA\   0.0039 ± 0.0020            0.0038 ± 0.0021              0.0041 ± 0.0023                  0.0038 ± 0.0021                0.851
  /\                                                                                                                                      
  10,11‐EDP                                                                                                                               

  13,14‐DiHDPA\   0.0101 ± 0.0082            0.0085 ± 0.0067              0.0081 ± 0.0063                  0.0081 ± 0.0063                0.169
  /\                                                                                                                                      
  13,14‐EDP                                                                                                                               

  16,17‐DiHDPA\   0.0089 ± 0.0103            0.0083 ± 0.0098              0.0110 ± 0.0089                  0.0091 ± 0.0077                0.734
  /\                                                                                                                                      
  16,17‐EDP                                                                                                                               

  19,20‐DiHDPA\   0.0019 ± 0.0047            0.0022 ± 0.0054              0.0019 ± 0.0046                  0                              0.606
  /\                                                                                                                                      
  19,20‐EDP                                                                                                                               
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Together the results indicate that differences in the total RBC levels of 9,10‐EpOME, 12,13‐EpOME, 5,6‐EET, 11,12‐EET, 14,15‐EET), 16,17‐EDP, 19,20‐EDP occur from increased production and accumulation, rather than altered sEH activity during acute, maximal exercise. Since inhibitors of sEH are in clinical development, these findings could be important for patients.

*Trans*‐epoxides {#phy214275-sec-0008}
----------------

*Trans*‐EETs are stored in phospholipids and in RBCs in the circulation, and have been proposed to contribute to the antihypertensive effects of sEH inhibitors in rats (Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). We measured trans‐epoxy fatty acids in RBCs. We observed that *trans*‐EETs, *trans*‐EEQs, and *trans*‐EDPs are stored at significant levels in human RBCs (Table [8](#phy214275-tbl-0008){ref-type="table"}). The total concentrations of these *trans*‐metabolites are \~ 1.5‐2‐fold lower than the concentrations of their respective *cis*‐metabolites (cf. Table [3](#phy214275-tbl-0003){ref-type="table"}; Table [9](#phy214275-tbl-0009){ref-type="table"}). No changes occurred in the *trans*‐metabolites in response to exercise (Table [8](#phy214275-tbl-0008){ref-type="table"}). Similar results were observed for free *trans*‐EETs, *trans*‐EEQs and *trans*‐EDPs (Table [10](#phy214275-tbl-0010){ref-type="table"}). Our results suggest that these RBC *trans*‐epoxides presumably do not contribute to the metabolic and hemodynamic response in acute, maximal exercise.

###### 

Total *trans*‐metabolites in erythrocytes in response to exhaustive exercise (*n* = 6).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolite\       Time point 1 (rest),\   Time point 2 (HF 150),\   Time point 3 (exhaustion),\   Time point 4 (recovery),\   Greenhouse--Geisser, *P* value
  (ng/g)            *P1*                    *P2*                      *P3*                          *P4*                        
  ----------------- ----------------------- ------------------------- ----------------------------- --------------------------- --------------------------------
  5,6‐EET trans     30.05 ± 11.03           26.83 ± 4.98              30.78 ± 7.34                  30.17 ± 6.18                0.386

  8,9‐EET trans     44.41 ± 13.64           39.18 ± 7.17              45.11 ± 10.86                 48.67 ± 8.84                0.280

  11,12‐EET trans   47.38 ± 15.21           44.90 ± 9.08              50.60 ± 12.36                 52.31 ± 9.96                0.388

  14,15‐EET trans   39.00 ± 12.52           36.16 ± 6.14              41.68 ± 9.19                  43.40 ± 7.57                0.296

  8,9‐EEQ trans     0                       0                         0                             0                           n/a

  11,12‐EEQ trans   0.99 ± 0.32             1.05 ± 0.30               1.05 ± 0.22                   1.04 ± 0.18                 0.887

  14,15‐EEQ trans   1.89 ± 0.52             1.84 ± 0.50               2.01 ± 0.53                   2.25 ± 0.57                 0.088

  17,18‐EEQ\        2.40 ± 0.57             2.43 ± 0.53               2.42 ± 0.73                   2.43 ± 0.54                 0.99
  trans                                                                                                                         

  7,8‐EDP trans     11.59 ± 1.22            10.00 ± 1.55              11.73 ± 2.25                  12.44 ± 2.79                0.160

  10,11‐EDP trans   33.23 ± 5.52            30.44 ± 5.02              34.73 ± 7.43                  36.68 ± 8.70                0.242

  13,14‐EDP trans   14.23 ± 1.62            13.66 ± 2.26              15.46 ± 3.26                  16.17 ± 4.13                0.267

  16,17‐EDP trans   17.03 ± 2.06            15.16 ± 2.17              17.77 ± 4.20                  17.98 ± 4.73                0.207

  19,20‐EDP trans   13.72 ± 1.94            12.28 ± 1.96              14.09 ± 3.29                  15.15 ± 4.17                0.249
  --------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Ratios of total *cis*‐metabolites versus total trans‐metabolites in erythrocytes (*n* = 6).

  ---------------------------------------------------------------------------------------------------
  Metabolite\   *Cis*, Time point 1 (rest),\   *Trans*, Time point 1 (rest),\   Ratio (*Cis/Trans*)
  (ng/g)        *P1*                           *P1*                             
  ------------- ------------------------------ -------------------------------- ---------------------
  5,6‐EET       54.75 ± 6.93                   30.05 ± 11.03                    1.8

  8,9‐EET       70.70 ± 11.08                  44.41 ± 13.64                    1.6

  11,12‐EET     71.69 ± 9.72                   47.38 ± 15.21                    1.6

  14,15‐EET     79.97 ± 13.23                  39.00 ± 12.52                    2.1

  11,12‐EEQ     2.38 ± 0.78                    0.99 ± 0.32                      2.4

  14,15‐EEQ     2.67 ± 0.86                    1.89 ± 0.52                      1.4

  17,18‐EEQ     3.62 ± 0.94                    2.40 ± 0.57                      1.5

  7,8‐EDP       29.72 ± 5.06                   11.59 ± 1.22                     2.6

  10,11‐EDP     42.64 ± 7.31                   33.23 ± 5.52                     1.3

  13,14‐EDP     21.34 ± 4.31                   14.23 ± 1.62                     1.5

  16,17‐EDP     27.04 ± 3.95                   17.03 ± 2.06                     1.6

  19,20‐EDP     26.50 ± 4.83                   13.72 ± 1.94                     1.9
  ---------------------------------------------------------------------------------------------------
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###### 

Free *trans*‐metabolites in blood plasma in response to exhaustive exercise (*n* = 6).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolite\       Time point 1 (rest),*P1*   Time point 2 (HF 150),*P2*   Time point 3 (exhaustion),*P3*   Time point 4 (recovery),*P4*   Greenhouse--Geisser, *P* value
  (ng/ml)                                                                                                                                   
  ----------------- -------------------------- ---------------------------- -------------------------------- ------------------------------ --------------------------------
  5,6‐EET trans     2.77 ± 0.67                3.01 ± 1.14                  2.74 ± 0.99                      2.59 ± 0.67                    0.458

  8,9‐EET trans     4.43 ± 1.18                4.95 ± 1.55                  4.44 ± 1.35                      4.15 ± 1.17                    0.296

  11,12‐EET trans   4.70 ± 1.23                5.05 ± 1.60                  4.50 ± 1.52                      4.15 ± 1.27                    0.306

  14,15‐EET trans   3.81 ± 0.97                4.05 ± 1.32                  3.69 ± 1.14                      3,53 ± 1.16                    0.461

  8,9‐EEQ trans     0.16 ± 0.07                0.18 ± 0.06                  0.20 ± 0.08                      0.18 ± 0.07                    0.525

  11,12‐EEQ trans   0.33 ± 0.08                0.30 ± 0.13                  0.32 ± 0.08                      0.27 ± 0.10                    0.444

  14,15‐EEQ trans   0.38 ± 0.08                0.37 ± 0.11                  0.35 ± 0.07                      0.33 ± 0.12                    0.293

  17,18‐EEQ\        0.45 ± 0.09                0.46 ± 0.14                  0.45 ± 0.14                      0.41 ± 0.12                    0.539
  trans                                                                                                                                     

  7,8‐EDP trans     1.15 ± 0.22                1.30 ± 0.48                  1.18 ± 0.43                      1.05 ± 0.21                    0.328

  10,11‐EDP trans   3.36 ± 0.65                3.66 ± 1.47                  3.35 ± 1.34                      2.92 ± 0.58                    0.347

  13,14‐EDP trans   1.37 ± 0.58                1.42 ± 0.51                  1.28 ± 0.42                      1.26 ± 0.21                    0.531

  16,17‐EDP trans   1.29 ± 0.35                1.35 ± 0.56                  1.16 ± 0.51                      1.06 ± 0.27                    0.138

  19,20‐EDP trans   1.34 ± 0.33                1.49 ± 0.55                  1.30 ± 0.54                      1.22 ± 0.29                    0.403
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Discussion {#phy214275-sec-0009}
==========

To the best of our knowledge, we conducted the first study on the impact of acute exercise on eicosanoids in RBCs. Epoxy‐metabolite and hydroxy RBC profiling was performed on venous blood taken form healthy individuals. The volunteers were subjected to maximal treadmill exercise using the standard Bruce protocol. This protocol induces strong and robust hemodynamic and metabolic changes (Bruce et al., [1973](#phy214275-bib-0001){ref-type="ref"}; Trappe and Lollgen, [2000](#phy214275-bib-0025){ref-type="ref"}). We confirmed our hypothesis that individual RBC EETs and EDPs are influenced by acute, exhaustive exercise, but *trans*‐epoxy and LOX metabolites are not. These findings indicate involvement of CYP. These changes were associated with heart rate, systolic blood pressure, and serum lactate increases, which occurred at 13.5 METs. Our results indicate that RBC could represent a reservoir for PUFA CYP epoxy‐metabolites, which on release may act in a vasoregulatory capacity to affect hemodynamics in acute, maximal exercise.

EETs {#phy214275-sec-0010}
----

RBCs have been implicated to serve as a reservoir for EETs which on release may act in a vasoregulatory capacity (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). In addition to serving as carriers of O~2~, RBCs regulate vascular resistance and the distribution of microvascular perfusion by liberating ATP and EETs upon exposure to a low O~2~ environment (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Sprague, [2010](#phy214275-bib-0024){ref-type="ref"}). The release of EETs is activated by ATP stimulation *via* P2X~7~ receptors coupled to ATP transporters to amplify the circulatory response to ATP (Jiang et al., [2007](#phy214275-bib-0013){ref-type="ref"}). RBCs are reservoirs of EETs. As a matter of fact, RBC may serve as a primary source of plasma EETs, which are esterified to the phospholipids of lipoproteins. Levels of free EETs in plasma are reduced, namely in the range of \~3% of circulating EETs (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). RBC EETs are produced by direct oxidation of arachidonic acid (AA) esterified to glycerophospholipids and the monooxygenase‐like activity of hemoglobin (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}; Jiang et al., [2012](#phy214275-bib-0016){ref-type="ref"}). On release, EETs exert effects on vascular tone and blood pressure. In addition, EETs produce pro‐fibrinolysis and reduce inflammation (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}; Jiang et al., [2012](#phy214275-bib-0016){ref-type="ref"}). An sEH is now recognized to regulate the RBC EET levels by EET catabolism into DHETs ( Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). Our results demonstrate that physical exercise affects the RBC CYP epoxy‐metabolite status, which could contribute to the hemodynamic and metabolic response in acute, exhausting exercise. In particular, we observed increases in total concentrations of EETs (5,6‐EET, 11,12‐EET, 14,15‐EET) in RBCs, which are potent vasodilators (Jiang et al., [2010](#phy214275-bib-0014){ref-type="ref"}; Sprague, [2010](#phy214275-bib-0024){ref-type="ref"}; Jiang et al., [2011](#phy214275-bib-0015){ref-type="ref"}). We did not observe an increase in RBC DHETs levels. DHETs were initially thought to be inactivation products of EETs. Nonetheless, recent studies indicate that, like EETs, they produce vasodilation (Hercule et al., [2009](#phy214275-bib-0010){ref-type="ref"}), possibly by activating BK~Ca~ channels in vascular smooth muscle cells (Lu et al., [2001](#phy214275-bib-0017){ref-type="ref"}). It is unknown whether RBCs are capable of liberating DHETs upon exposure to a low O~2~ environment or ATP. Our results indicate that short‐term maximal exercise affects the RBC reservoir for EETs, but not DHETs, which on release may act in a vasoregulatory capacity to affect the cardiovascular response.

Other PUFA metabolites {#phy214275-sec-0011}
----------------------

We observed increases in total concentrations of EDPs (16,17‐EDP, 19,20‐EDP) and EpOMEs (9,10‐EpOME and 12,13‐EpOME) in RBCs during maximal exercise. 16,17‐EDP and 19,20‐EDP are potent vasodilators in coronary, pulmonary and mesenteric arteries and can lower blood pressure and exhibit cardioprotection by preservation of mitochondrial function (Morin et al., [2011](#phy214275-bib-0018){ref-type="ref"}; Schunck et al., [2017](#phy214275-bib-0020){ref-type="ref"}). In contrast, 9,10‐EpOME and 12,13‐EpOME are reported to represent vasoconstrictors in severe cardiac ischemia (Siegfried et al., [1990](#phy214275-bib-0021){ref-type="ref"}; Dudda et al., [1996](#phy214275-bib-0004){ref-type="ref"}). However, it is unknown whether RBCs are capable of liberating EDPs or EpOMEs upon exposure to a low O~2~ environment or ATP. Our data indicate that both metabolites are novel candidates for vasoactive substances potentially released by RBCs upon maximal exercise to affect hemodynamics in these conditions.

Furthermore, we observed that total levels of the CYP metabolites 5,6‐EEQ, 8,9‐EEQ, 11,12‐EEQ, 14,15‐EEQ, 8,9‐EET, 10,11‐EDP, and 13,14‐EDP in RBCs were not influenced by acute, exhaustive exercise. Similar effects were observed for the LOX metabolites 5‐HEPE, 8‐HEPE, 9‐HEPE, 12‐HEPE, 15‐HEPE, 18‐HEPE, 5‐HETE, 8‐HETE, 9‐HETE, 11‐HETE, 12‐HETE, 15‐HETE, 4‐HDHA, 7‐HDHA, 8‐HDHA, 10‐HDHA, 11‐HDHA, 13‐HDHA, 14‐HDHA, 16‐HDHA, 17‐HDHA, 20‐HDHA, and 13‐HODE. EEQs levels were low because the subjects did not receive long chain n‐3 fatty acid supplementation. The steadiness of the HDHAs and HEPEs is of particular interest because these DHA and EPA‐derived metabolites are the precursors of the D‐ and E‐series of resolvins. Resolvins are members of a novel class of lipid mediators that have highly potent antiinflammatory and pro‐resolution properties (Fischer et al., [2014](#phy214275-bib-0005){ref-type="ref"}). Together, the data suggest that these PUFA metabolites are unlikely to play a role in the cardiovascular response caused by short‐term exercise.

Diols {#phy214275-sec-0012}
-----

sEH converts EETs to DHETs, EpOMEs to DiHOMEs, EEQs to DiHETEs, EDPs to DiHDPAs (Fig. [1](#phy214275-fig-0001){ref-type="fig"}) and inhibition of sEH is a potential approach for enhancing the biological activity of EETs (Spector and Kim, [2015](#phy214275-bib-0022){ref-type="ref"}). However, presumably higher levels of EETs in blood and tissue *in vivo* may have also detrimental cardiovascular side effects, such as increased risk of ischemic stroke (Gschwendtner et al., [2008](#phy214275-bib-0008){ref-type="ref"}) and higher recurrence of atrial fibrillation after catheter ablation in humans (Wutzler et al., [2013](#phy214275-bib-0027){ref-type="ref"}), and reduced survival after cardiac arrest and cardiopulmonary resuscitation in mice (Hutchens et al., [2008](#phy214275-bib-0012){ref-type="ref"}). We cannot exclude that the higher levels of EETs, EDPs, and EPOMEs in RBCs during maximal exercise result from sEH inhibition. However, this is rather unlikely since our ratio analyses argue against this possibility. Furthermore, the DHET, DiHOME and DiHDPA levels did also not vary during acute, exhausting exercise in healthy volunteers. Finally, short‐term exhaustive exercise did not cause increased mobilization of individual free epoxy‐metabolites into RBC plasma. Nevertheless, the effects of the erythro‐DHETs, erythro‐DiHOMEs, erythro‐DiHDPAs has yet to be integrated into a patho‐physiological context.

Epoxy‐metabolites in the recovery period {#phy214275-sec-0013}
----------------------------------------

Accumulation of total 5,6‐EET, 11,12‐EET, 14,15‐EET, 16,17‐EDP, 19,20‐EDP, 9,10‐EpOME, and 12,13‐EpOME levels in RBCs persisted in the recovery period (10 min). The reason is unclear but may represent a phenomenon similar to the recovery pulse sum, which becomes larger when the loading intensity is above the long‐term performance limit. We suspect that levels of 5,6‐EET, 11,12‐EET, 14,15‐EET, 16,17‐EDP, 19,20‐EDP, 9,10‐EpOME, and 11,12‐EpOME in RBCs will return to normal levels after a longer resting time interval.

Exercise protocol considerations {#phy214275-sec-0014}
--------------------------------

The Bruce‐protocol was used to ensure that all runners were able to complete a similar highest intensity workload concomitant with robust and significant increases in hemodynamics without fatiguing. Our clinical data (Table [2](#phy214275-tbl-0002){ref-type="table"}) show that the protocol caused the expected hemodynamic and metabolic responses.

Limitations {#phy214275-sec-0015}
-----------

Our treadmill testing was primarily developed to identify ischemic heart disease; fortunately, none of our subjects had this condition. Other exhaustive protocols might have been better. Furthermore, the workload was increased in large increments. Primarily the leg musculature was stressed. We obtained venous blood samples and perhaps a source closer to contracting muscle would have been more elucidative (Giordano et al., [2011](#phy214275-bib-0006){ref-type="ref"}). We studied effects of maximal short‐term exercise and therefore cannot comment on endurance exercise. Possibly, different results would have been obtained.

Conclusions {#phy214275-sec-0016}
===========

Our results suggest that maximal exercise affects the levels of numerous CYP epoxy‐metabolites in RBCs. We suggest that RBCs are reservoir for EETs and possibly other epoxide fatty acids, which on release may act in a vasoregulatory capacity. More research is needed to delineate the contribution of RBC epoxy‐metabolites to cardiac performance and skeletal‐muscle blood flow in health and disease.
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